2025-09-06 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group (UNH) based on the data provided, presented in a structured report format.

## UnitedHealth Group Inc (UNH) Stock Analysis

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 20.96%
*   **VOO Cumulative Return:** 101.31%
*   **Return Disparity:** -80.35%
*   **Disparity Range:**
    *   Max: 55.3
    *   Min: -101.4
    *   Current: -82.1
    *   Relative Disparity: 12.3
    

**Analysis:**

UNH has significantly underperformed the S&P 500 (VOO) over the analyzed period. The cumulative return disparity is a substantial -80.35%. The relative disparity of 12.3 suggests that the current underperformance is near the lower end of its historical range compared to the S&P 500, indicating it has been worse off previously.

### Alpha, Beta Analysis

| Year      | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
| :---------- | :------ | :------ | :----- | :--- | :------- |
| 2015-2017 | 65.0%   | 56.6%   | 36.0%  | 0.0  | 199.7  |
| 2016-2018 | 52.0%   | 63.7%   | 34.0%  | 0.0  | 225.6  |
| 2017-2019 | 38.0%   | 63.7%   | 9.0%   | 0.3  | 266.2  |
| 2018-2020 | -21.0%  | 63.7%   | -40.0% | 0.4  | 317.6  |
| 2019-2021 | 36.0%   | 61.0%   | -13.0% | 0.4  | 454.8  |
| 2020-2022 | 28.0%   | 66.9%   | 26.0%  | 0.4  | 480.2  |
| 2021-2023 | 33.0%   | 67.5%   | 15.0%  | 0.4  | 476.8  |
| 2022-2024 | -31.0%  | 68.6%   | -57.0% | 0.3  | 458.1  |
| 2023-2025 | -55.0%  | 75.7%   | -108.0% | 0.1  | 285.6  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant volatility, ranging from negative values to as high as 65%. Recent years show a decline in CAGR.
*   **MDD:** Maximum Drawdown (MDD) is consistently high, indicating significant potential for losses during downturns.
*   **Alpha:** Alpha measures the investment's performance relative to a benchmark (risk-adjusted return). UNH shows periods of both outperformance (positive Alpha) and underperformance (negative Alpha) compared to its benchmark, with recent years showing significant underperformance.
*   **Beta:** Beta measures the investment's volatility relative to the market. A Beta around 0.3 to 0.4 suggests that UNH is less volatile than the overall market.
*   **Cap(B):** Market capitalization in billions, showing the growth and later decline in the company's value over the periods.

### 2. Recent Price Action

*   **Current Price:** 315.39
*   **Previous Close:** 310.38
*   **Price Change:** 1.61%
*   **5-day Moving Average:** 309.75
*   **20-day Moving Average:** 294.79
*   **60-day Moving Average:** 291.84

**Analysis:**

The stock is trading above its 5, 20, and 60-day moving averages, indicating a short-term uptrend. The positive price change from the previous close suggests recent buying pressure.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 60.33 (Approaching Overbought)
*   **PPO:** 0.68
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **20-day Relative Disparity Change:** +0.9 (Short-term Increase)
*   **Expected Return:** 56.1% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates a "Low Risk" environment.
*   **RSI:** The RSI value suggests the stock is approaching overbought territory, which could signal a potential pullback.
*   **PPO:** The Positive Price Oscillator (PPO) indicates the percentage that a faster moving average is above a slower moving average.
*   **Hybrid Signal:** Recommends a partial buy, suggesting cautious optimism.
*   **20-day Relative Disparity Change:** The recent increase in relative disparity suggests short-term upward momentum compared to the S&P 500, but it follows a prolonged period of underperformance.
*   **Expected Return:** The high expected return suggests potential for significant outperformance relative to the S&P 500 over the long term (2+ years).

Given the recent price change (+1.61%), which indicates a quick rebound, it is a positive sign for short-term momentum.

### 4. Recent News & Significant Events

*   **Medicare Audit Concerns:** "Medicare Audit Blitz Hits a Wall" suggests uncertainty around potential overpayments.
*   **Bull Case Theory:** "UnitedHealth Group Incorporated (UNH): A Bull Case Theory" presents a positive outlook.
*   **Analyst Price Target Increases:** Bernstein and Barclays have increased their price targets on UNH, indicating positive sentiment.
*   **Elizabeth Warren's Scrutiny:** "Elizabeth Warren Is Taking Aim at UnitedHealth" introduces regulatory risk.
*   **Healthcare Sector Resurgence:** "Healthcare Stocks Are Just Starting Their Resurgence" suggests a positive outlook for the sector.

**Analysis:**

The news is mixed. Positive analyst ratings and a "bull case" article are encouraging. However, regulatory scrutiny from Elizabeth Warren and concerns about Medicare audits introduce risks. The broader healthcare sector outlook is positive.

### 4-2) Analyst Opinions

*   **Consensus:** Buy (1.92 on a 1-5 scale)
*   **Target Price:** $330.08 (Average)
*   **Recent Rating Changes:** No recent changes indicated.

**Analysis:**

The analyst consensus is generally positive ("Buy"), with an average target price suggesting some upside potential from the current price.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue       |
| :--------- | :--- | :------------ |
| 2025-08-11 | 3.76 | $111.62B      |
| 2025-05-07 | 6.9  | $109.58B      |
| 2024-11-04 | 6.56 | $100.82B      |
| 2024-08-09 | 4.58 | $98.86B       |
| 2025-08-11 | 4.58 | $98.86B       |

**Analysis:**

Revenue has generally been increasing over the past year. EPS shows some volatility, but the overall trend is positive.

### 6. Financial Information

| Quarter    | Revenue      | Profit Margin |
| :--------- | :----------- | :------------ |
| 2025-06-30 | $111.62B     | 17.93%        |
| 2025-03-31 | $109.58B     | 21.70%        |
| 2024-12-31 | $100.81B     | 21.14%        |
| 2024-09-30 | $100.82B     | 22.84%        |
| 2024-06-30 | $98.86B      | 22.31%        |

| Quarter    | Equity       | ROE    |
| :--------- | :----------- | :----- |
| 2025-06-30 | $94.72B     | 3.60%  |
| 2025-03-31 | $95.04B     | 6.62%  |
| 2024-12-31 | $92.66B     | 5.98%  |
| 2024-09-30 | $94.53B     | 6.41%  |
| 2024-06-30 | $89.36B     | 4.72%  |

**Analysis:**

*   **Revenue:** Consistent revenue growth is evident.
*   **Profit Margin:** Profit margins have fluctuated, with a recent dip.
*   **Equity:** Equity has shown growth.
*   **ROE:** Return on Equity (ROE) has fluctuated, reflecting changes in profitability and equity.

### 7. Overall Assessment

UNH has significantly underperformed the S&P 500 recently, but analyst opinions and the expected return suggest long-term potential. However, potential regulatory scrutiny, potential Medicare audit issues, and high historical maximum drawdowns should be carefully considered. The recent price action is positive, but the RSI indicates the stock may be approaching overbought conditions. The low MRI indicates a lower risk environment.
